Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
5
×
boston blog main
boston top stories
eli lilly
5
×
life sciences
national blog main
san francisco blog main
biotech
deals
san francisco top stories
clinical trials
indiana blog main
national top stories
avapritinib
blueprint medicines
boehringer ingelheim
fda
genentech
indiana top stories
investing
medullary thyroid cancer
new york blog main
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
alexion pharmaceuticals
alnylam pharmaceutials
arrowhead pharmaceuticals
arrowmark partners
beta bionics
bigfoot biomedical
biontech
boston university
cancer
cancer drugs
capmatinib
congenital hyperinsulinism
cstone pharmaceuticals
What
medicines
cancer
approval
blueprint
companies
deal
drug
fda
latest
ret
rna
abandoning
address
ago
approves
baggage
beta
bets
bio
bionics
blood
candidate
carries
certain
closed
comes
currently
cut
cuts
date
designed
developing
development
device
diabetes
dicerna
driven
effective
enticed
evidence
Language
unset
Current search:
boston
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
